These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Stimulation of melatonin receptors decreases calcium levels in xenopus tectal cells by activating GABA(C) receptors. Prada C; Udin SB; Wiechmann AF; Zhdanova IV J Neurophysiol; 2005 Aug; 94(2):968-78. PubMed ID: 15817645 [TBL] [Abstract][Full Text] [Related]
45. The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro. Imbesi M; Arslan AD; Yildiz S; Sharma R; Gavin D; Tun N; Manev H; Uz T J Pineal Res; 2009 Jan; 46(1):87-94. PubMed ID: 18798788 [TBL] [Abstract][Full Text] [Related]
46. Does a melatonin-dependent circadian oscillator in the pars tuberalis drive prolactin seasonal rhythmicity? Dardente H J Neuroendocrinol; 2007 Aug; 19(8):657-66. PubMed ID: 17620107 [TBL] [Abstract][Full Text] [Related]
48. Melatonin: a chemical photoperiodic signal with clinical significance in humans. Pang SF; Pang CS; Poon AM; Lee PP; Liu ZM; Shiu SY Chin Med J (Engl); 1998 Mar; 111(3):197-203. PubMed ID: 10374414 [TBL] [Abstract][Full Text] [Related]
49. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527 [TBL] [Abstract][Full Text] [Related]
50. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Blask DE; Dauchy RT; Brainard GC; Hanifin JP Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410 [TBL] [Abstract][Full Text] [Related]
51. Melatonin and its agonists in pain modulation and its clinical application. Srinivasan V; Zakaria R; Jeet Singh H; Acuna-Castroviejo D Arch Ital Biol; 2012 Dec; 150(4):274-89. PubMed ID: 23479460 [TBL] [Abstract][Full Text] [Related]
52. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders. Hardeland R Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175 [TBL] [Abstract][Full Text] [Related]
54. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. Hardeland R; Madrid JA; Tan DX; Reiter RJ J Pineal Res; 2012 Mar; 52(2):139-66. PubMed ID: 22034907 [TBL] [Abstract][Full Text] [Related]
55. Melatonin: a master hormone and a candidate for universal panacea. Kumar V Indian J Exp Biol; 1996 May; 34(5):391-402. PubMed ID: 9063071 [TBL] [Abstract][Full Text] [Related]
57. Novel molecular mechanisms for the adaptogenic effects of herbal extracts on isolated brain cells using systems biology. Panossian A; Seo EJ; Efferth T Phytomedicine; 2018 Nov; 50():257-284. PubMed ID: 30466987 [TBL] [Abstract][Full Text] [Related]
58. Membrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease. Nikolaev G; Robeva R; Konakchieva R Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008896 [TBL] [Abstract][Full Text] [Related]
59. Physiological and metabolic functions of melatonin. Barrenetxe J; Delagrange P; MartÃnez JA J Physiol Biochem; 2004 Mar; 60(1):61-72. PubMed ID: 15352385 [TBL] [Abstract][Full Text] [Related]